CUPR Stock Summary and Trading Ideas (Cuprina Holdings (Cayman) Limited - Class A | NASDAQ:CUPR)

Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.

Cuprina Holdings (Cayman) Limited - Class A trades on the NASDAQ stock market under the symbol CUPR.

As of June 18, 2026, CUPR stock price declined to $4.37 with 222,034 million shares trading.

CUPR has a beta of 0.48, meaning it tends to be less sensitive to market movements. CUPR has a correlation of 0.00 to the broad based SPY ETF.

CUPR has a market cap of $11.72 million. This is considered a Sub-Micro Cap stock.

CUPR has underperformed the market in the last year with a return of -89.8%, while SPY returned +26.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CUPR shares. However, CUPR has outperformed the market in the last 3 month and 2 week periods, returning +60.6% and +54.4%, while SPY returned +11.6% and -1.0%, respectively. This indicates CUPR has been having a stronger performance recently.

CUPR support price is $4.26 and resistance is $6.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CUPR shares will trade within this expected range on the day.